Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

POINT Biopharma Global Inc. - Common Stock (NQ: PNT )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Dec 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about POINT Biopharma Global Inc. - Common Stock

< Previous 1 2 3 4 Next >
Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday's Mid-Day Session
Gainers Akerna Corp. (NASDAQ: KERN) shares rose 81.2% to $0.2355 after gaining 8% on Tuesday. 
Via Benzinga
Nucor, Altimmune And Some Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Wednesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Thanks To Encouraging Data, These Mid-Cap Stocks Layout $300M Equity Raise
Via Benzinga
POINT Biopharma Shares Jump After Updated Efficacy, Safety Data From Prostate Cancer Candidate
Via Benzinga
Recap: POINT Biopharma Global Q2 Earnings
  POINT Biopharma Global (NASDAQ:PNT) reported its Q2 earnings results on Friday, August 12, 2022 at 08:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Why POINT Biopharma Shares Are Getting Hammered
POINT Biopharma Global Inc (NASDAQ: PNT) shares are trading lower by 11.41% to $9.01 Wednesday morning after the company priced a public offering of 13.9 million shares of common stock at $9 per share.... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
  
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting off Wednesday with an overview of the biggest pre-market stock movers this morning and the news moving those shares! 
Via InvestorPlace
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split. 
Via Benzinga
Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session
Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
Upgrades 
Via Benzinga
Peering Into POINT Biopharma Global's Recent Short Interest
POINT Biopharma Global's (NASDAQ:PNT) short percent of float has fallen 3.57% since its last report. The company recently reported that it has 12.90 million shares sold short... 
Via Benzinga
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
  
Via Benzinga
Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session
Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2022
  
Via Benzinga
Earnings Scheduled For August 12, 2022
Companies Reporting Before The Bell • NeoGenomics (NASDAQ:NEO) is projected to report quarterly earnings at $0.44 per share on revenue of $218.26 million. 
Via Benzinga
Preview: POINT Biopharma Global's Earnings
  POINT Biopharma Global (NASDAQ:PNT) is set to give its latest quarterly earnings report on Friday, 2022-08-12. Here's what investors need to know before the announcement. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2022
Upgrades 
Via Benzinga
Earnings Scheduled For May 13, 2022
Companies Reporting Before The Bell • Codere Online Luxembourg (NASDAQ:CDRO) is estimated to report quarterly loss at $0.13 per share on revenue of $20.08 million. 
Via Benzinga
35 Stocks Moving In Monday's Mid-Day Session
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) jumped 57.1% to $1.96 following reports regarding potential future investments from AMC CEO, Adam Aron.... 
Via Benzinga
50 Biggest Movers From Yesterday
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares gained 81.3% to close at $2.32 on Monday. Last week, AMC Entertainment Holdings purchased a major stake in... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers OncoSec Medical (NASDAQ:ONCS) shares moved upwards by 27.1% to $1.5 during Monday's pre-market session. The company's market cap stands at $59.0 million.... 
Via Benzinga
The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
Earnings Scheduled For March 25, 2022
Companies Reporting Before The Bell DXP Enterprises, Inc. (NASDAQ: DXPE) is expected to report quarterly earnings at $0.14 per share on revenue of $285.00 million. BRP... 
Via Benzinga
This Company Is Making Progress In Its Fight Against Rare, Terminal Cancers
Photo by National Cancer Institute on Unsplash 
Via Benzinga
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Mustang Bio (NASDAQ:MBIO) shares ... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.